About the Program
Program Overview
The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the HIV Glasgow Drug Therapy Congress (HIV Glasgow 2018). This program consists of four components: (1) CME Internet Symposium: HIV Glasgow 2018 Expert Review: a 1.5 hour internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) European Perspective on HIV Glasgow 2018: a 1 hour panel discussion featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (3) Rapid-Fire Review of HIV Glasgow 2018: a podcast that provides a brief audio summary of the most essential data presented at the conference; and (4) From Conference to Clinic: Reviewing and Applying Data From HIV Glasgow 2018: case-based dinner meetings during which the key data are reviewed, discussed, and applied to patient care.
The CME Internet Symposium: HIV Glasgow 2018 Expert Review will feature a panel of HIV experts reviewing and discussing key presentations on antiretroviral therapy presented at HIV Glasgow 2018. The review and discussion will focus on HIV therapeutic options and developments, including: current treatment and management strategies, algorithms and recommendations, therapies in development, epidemiology, and diagnosis and clinical management of specific patient populations. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All online components of the program can be accessed at www.viraled.com.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at HIV Glasgow 2018 and it is not sanctioned by the organizers of HIV Glasgow 2018.
Media: Internet
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the care of patients with HIV infection.
Learning Objectives
After completing this activity, participants should be better able to:
- Review data reported at HIV Glasgow 2018 for counseling, testing, and antiretroviral treatment to prevent HIV infection, especially in underserved communities
- Relate in a clinical setting, findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at HIV Glasgow 2018
- Employ strategies based on studies and data presented at HIV Glasgow 2018 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care
- Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at HIV Glasgow 2018 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS
Release Date: November 21, 2018
Expiration Date: November 21, 2019
Estimated time to complete the program: 1 hour, 30 minutes
Faculty
José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
Marta Boffito, MD, PhD
St. Stephen’s AIDS Trust and Imperial College
Chelsea and Westminster Hospital
London, United Kingdom
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom
Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine
University Hospital
Bonn, Germany
Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
Joint Accreditation Statement
|
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
For Complete Program
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Individual Modules
Hot Topics and Prevention
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Studies in Treatment-Naive and Treatment Experienced Patients
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Salvage Therapy and Co-infections
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Adverse Events
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Pharmacology
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors,
planners, managers and other individuals who are in a position to
control the content of this activity to disclose any real or apparent
conflict of interest (COI) they may have as related to the content of
this activity. All identified COI are thoroughly vetted and resolved
according to PIM policy. PIM is committed to providing its learners
with high quality CME activities and related materials that promote
improvements or quality in healthcare and not a specific proprietary
business interest of a commercial interest.
The faculty reported the following financial
relationships or relationships to products or devices they or their
spouse/life partner have with commercial interests related to the
content of these CME activities:
Jose Arribas, MD
- Consulting Fees: Merck, Gilead, ViiV, Gilead, Janssen
Marta Boffito, MD
- Consulting Fees: Gilead, BMS, ViiV
- Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead, Janssen, ViiV, BMS
- Contracted Research: ViiV, Gilead, Janssen, BMS
Ian Frank, MD
- Consulting Fees: Gilead, ViiV
Graeme Moyle, MD
- Consulting Fees: Gilead, Merck, Janssen
- Contracted Research: ViiV, Gilead, Amgen (to institution)
Juergen Rockstroh, MD
- Consulting Fees: Abbott, Abbivax, Gilead, Hexal, Janssen, Merck, ViiV
- Contracted Research: Gilead, Merck
Renslow Sherer, MD
The PIM planners and managers have nothing to disclose.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period, November 21, 2018 through November 21, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.
If
you wish to receive acknowledgment for completing this activity, please
complete the evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 13220. Upon registering and successfully completing the activity evaluation, your certificate
will be made available immediately.
Disclosure of Unlabeled Use
This
educational activity may contain discussion of published and/or investigational
uses of agents that are not indicated by the FDA. The planners of this activity
do not recommend the use of any agent outside of the labeled indications.
The
opinions expressed in the educational activity are those of the faculty and do
not necessarily represent the views of the planners. Please refer to the
official prescribing information for each product for discussion of approved
indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not meant to
serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed or
suggested in this activity should not be used by clinicians without
evaluation of their patient's conditions and possible contraindications
on dangers in use, review of any applicable manufacturer's product
information, and comparison with recommendations of other authorities.
Computer System Requirements
This
program requires a modern web browser (Internet Explorer 7+, Mozilla
Firefox, Apple Safari, Google Chrome). Certain educational activities
may require additional software to view multimedia, presentation, or
printable version of their content. These activities will be marked as
such and will provide links to the required software. That software may
be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint,
Windows Media Player and Real Networks Real One Player.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
*Greenwich Mean Time
|